Conference Coverage

March 30, 2017

Determining whether to approve expensive drugs: Top considerations

Weighing the ethics of approving expensive cancer drugs for patients is a multifaceted endeavor.

Payers strategize to manage opioid use

How managed care organizations manage opioid utilization and some of the limitations to those strategies was a hot topic at AMCP.

Creating a 'robust' specialty pharmacy network

The correct approach to take when creating a specialty pharmacy network is a key issue for healthcare executives.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

>>>>>>>